How we delivered 80 randomizations for an accelerated CVD trial [case study]

Recently, Antidote worked with a client to evaluate how the reduction of lipoprotein(a) affected the risk for major cardiac events — plus, the client needed this trial to launch in 6 weeks instead of the usual 12.

In this case study, we detail how we used population research and data-driven patient models to deliver 80 randomizations at a 96% randomization rate — all on an expedited launch timeline.